Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of “Buy” from Analysts
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) has earned an average recommendation of “Buy” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have covered the stock in the last […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) has earned an average recommendation of “Buy” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have covered the stock in the last […]
